Clinical trial
A Study of the Evalve® Cardiovascular Valve Repair (MitraClip®) System Endovascular Valve Edge-to-Edge REpair STudy (EVEREST II) EVEREST II High Risk Registry
NCT01940120 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Evalve® Cardiovascular Valve Repair (MitraClip®) System Endovascular Valve Edge-to-Edge REpair STudy (EVEREST II) EVEREST II High Risk Registry
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- February 28, 2013
- Enrollment
- 78 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
mitral insufficiency, mitral regurgitation, mitral valve incompetence, mitral valve insufficiency, mitral valve regurgitation